Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological crosstalk in human corneal and conjunctival epithelial cells
Open Access
- 6 January 2006
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 13 (9) , 1515-1522
- https://doi.org/10.1038/sj.cdd.4401835
Abstract
Extracellular plasminogen activator inhibitor type-2 (PAI-2) is a potent inhibitor of urokinase-type plasminogen activator (u-PA) and also acts as a multifunctional protein. However, the biological activity of intracellular PAI-2, as well as its intracellular targets, until now remain an enigma. Here, we show that pRb2/p130 and Rb1/p105, but not p107, interact with PAI-2 in both the cytoplasm and nucleus of normal primary human corneal and conjunctival epithelial cells. We provided the first in vivo evidence that a specific fragment of the PAI-2 promoter is bound simultaneously by pRb2/ p130, PAI-2, E2F5, histone deacetylase 1 (HDAC1), DNA methyltransferase 1 (DNMT1), and histone methyltransferase (SUV39H1), in normal primary human corneal epithelial cells, and by pRb2/p130, PAI-2, E2F5, HDAC1, and DNMT1, in normal primary human conjunctiva epithelial cells. Our results strongly indicate a physiological interaction between pRb family members and PAI-2, suggesting the hypothesis that pRb2/p130 and PAI-2 may cooperate in modulating PAI-2 gene expression by chromatin remodeling, in normal corneal and conjunctival cells.Keywords
This publication has 20 references indexed in Scilit:
- Plasminogen activator inhibitor type 2 (PAI-2) is present in normal human conjunctivaJournal of Cellular Physiology, 2005
- Structural Bases of the Redox-dependent Conformational Switch in the Serpin PAI-2Journal of Molecular Biology, 2004
- Genetic and epigenetic alterations as hallmarks of the intricate road to cancerOncogene, 2003
- Inhibition of Retinoblastoma Protein Degradation by Interaction with the Serpin Plasminogen Activator Inhibitor 2 via a Novel Consensus MotifMolecular and Cellular Biology, 2003
- Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs–pRb2/p130 complexesOncogene, 2003
- Transcriptional Repression by the Retinoblastoma Protein through the Recruitment of a Histone MethyltransferaseMolecular and Cellular Biology, 2001
- Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytesJournal of Cellular Physiology, 2000
- The retinoblastoma gene family in differentiation and developmentOncogene, 1999
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal DifferentiationJournal of Investigative Dermatology, 1998
- The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-α induced apoptosisCell Death & Differentiation, 1998